Accumulation of 5-Hydroxytryptamine by Aging Platelets: Studies in a Model of Suppressed Thrombopoiesis in Dogs

Summary

Thrombocytopenia was induced in healthy, male mongrel dogs by intramuscular injection of a single dose of estradiol valerate (1 mg/kg). A steady, almost linear decay of the blood platelet count starting about day 6 post-estradiol and attaining a mean value of 14 × 10³ platelets/pi one week later was observed. Thrombocytopenia is explained mainly by suppression- of thrombocytopoiesis, as established by two independent ways: 1. Megakaryocytes in the bone marrow were markedly reduced. 2. Kinetic studies with ¹¹‘In labeled autologous platelets revealed a nearly linear decay of the radioactivity and mean survival times within the expected range. The progressive reduction in the platelet count is associated with an increase in the mean age of the platelets still circulating. Following estradiol injection, platelet 5-hydroxytryptamine (5-HT) increased from a basal value of 130 ± 30 ng/10⁸ platelets (platelet count of 351 ± 53 × 10³ platelets/p.1) to 343 ± 100 ng/10⁸platelets eleven days latter, when the platelet count dropped to 32 ± 18 × 10³ platelets/pi No significant changes in the number or affinity of the 5-HT uptake receptors could be demonstrated in platelets exposed in vitro and in vivo to estradiol. Our results indicate that aging platelets accumulate 5-HT, probably by a sustained exposure to the monoamine in plasma, confirming previous observations based on models in which thrombopenia was induced by immune and mechanical means.

• References

• 1 Gaddum JH, Giarman NJ. Preliminary studies on the biosynthesis of 5-hydroxytryptamine. Brit J Pharmacol 1956; 11: 88-92
• 2 Morrissey JJ, Walker MN, Lovenberg W. The absence of tryptophan hydroxylase activity in blood platelets. Proc Soc Exp Biol Med 1977; 154: 496-9
• 3 Golino P, Piscione F, Willerson JT, Cappelli-Vigazzi M, Focaccio A. Villari B and cols. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991; 324: 641-8
• 4 Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF. In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemostas 1976; 35: 151-66
• 5 Reimers HJ, Allen DJ, Feuerstein IA, Mustard JF. Transport and storage of serotonin by thrombin-treated platelets. J Cell Biol 1975; 65: 359-72
• 6 Corash L. Platelet density heterogeneity and platelet ageing. In: Platelet Heterogeneity Biology and Pathology. Martin J, Trowbridge A. (eds) London; Springer-Verlag: 1990: 1-22
• 7 Corash L, Costa JL, Shafer B, Donlon JA, Muiphy D. Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood 1984; 64: 185-93
• 8 Mezzano D, Aranda E, Foradori A. Comparative study of size total protein fibrinogen and 5-HT content of human and canine platelets density subpopulations. Thromb Haemost 1986; 56: 288-92
• 9 Mezzano D, del Pino GE, Montesinos M, Garcia ME, Aranda E, Foradori A. Platelet 5-HT increases with platelet age in dogs. Thromb Haemostas 1991; 66: 254-8
• 10 Mezzano D, Aranda E, Rodriguez S, Foradori A, Lira P. Increase in den sity and accumulation of serotonin by human aging platelets. Am J Hematol 1984; 17: 11-21
• 11 Chiu T. Studies on estrogen-induced proliferative disorders of hemopoietic tissue in dogs. St. Paul: University of Minnesota. Ph. D. Thesis 1974; 1: 270
• 12 From AHL, Fong JSC, Chiu T, Good RA. Role of platelets in the pathogenesis of canine endotoxin shock. Infection Immunity 1976; 13: 1591-4
• 13 International Committee for Standarization in Hematology. Panel on Diagnostic Applications of Radionuclides. Recommended methods for Indium- 111 platelet survival studies. J Nuc Med 1988; 29: 564-6
• 14 Mezzano D, Aranda E, Foradori A, Rodriguez S, Lira P. Kinetics of platelet density subpopulations in splenectomized mongrel dogs. Am J Hematol 1984; 17: 373-82
• 15 Drummond AH, Gordon JL. Rapid sensitive microassay for platelet 5-HT. Thromb Diathes Haemorrh 1974; 31: 366-7
• 16 Sufi SB, Donaldson A, Jeffcoate SL. Estradiol Assay. In “Method Manual”. WHO Special Programme of Research Development and Training in Human Reproduction”. Geneva: WHO 1993; 52-62
• 17 Wielosz M, Salmonar M, de Gaetano G, Gerattini S. Uptake of ^l4C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. Arch Pharmacol. 1976; 296: 59-65
• 18 Costa JL, Murphy DL. Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature 1975; 255: 407-8
• 19 Capel-Edwards K, Hall DE, Sansom AG. Hematological changes observed in female beagle dogs given ethynylestradiol. Toxicol Appl Pharmacol 1971; 20: 319-26
• 20 Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985; 66: 1105-9
• 21 Mezzano D, Aranda E, Urzua J, Lema G, Habash J, Irarrazabal MJ, Pereira J. Changes in platelet beta-thromboglobulin, fibrinogen albumin, 5-hydroxytryptamine ATP and ADP during and after surgery with extracorporeal circulation in man. Ain J Hematol 1984; 22: 133-42